NCT04792853

Brief Summary

The purpose of this project is to pilot test a long-term effect of Tab-G (tablet-based cognitive behavioral group education intervention). The investigators will evaluate the effect of Tab-G, relative to usual care group, on (a) daily steps, (b) fatigue level, (c) self-efficacy and (d) quality of life. Tab-G participants will receive 4 weekly CBT-based group education focusing on shared goal setting and mutual reinforcement in a group with 5 members. The outcomes will be measured baseline, week 4 (intervention completion) and week 8 (follow-up). The investigators hypothesize that older adults receiving Tab-G will have greater improvements on outcomes compared to those receiving usual care at week 4, the intervention completion and at week 8 follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 21, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 11, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

May 9, 2023

Status Verified

May 1, 2023

Enrollment Period

2.3 years

First QC Date

March 7, 2021

Last Update Submit

May 8, 2023

Conditions

Keywords

arthritisfatiguecognitive behavioral therapygroup educationolder adultstabletsimple walking

Outcome Measures

Primary Outcomes (4)

  • daily steps

    daily step counts measured by an accelerometer

    24 hours

  • BRICS NINR PROMIS Fatigue Short Form 6a

    self-reported fatigue scale measuring both the experience of fatigue and the interference of fatigue on daily activities. Scores can range from 6 to 30, with higher scores indicating greater fatigue.

    past 1 week

  • Self-Efficacy for Managing Chronic Disease 6-Item Scale

    self-reported self-efficacy scale. Scores can range from 6 to 60, with higher scores indicating higher self-efficacy.

    24 hours

  • Quality of Life-Rheumatoid Arthritis Scale

    self-reported perception of quality of life. Scores can range from 8 to 80 with higher scores indicating greater quality of life.

    past 4 weeks

Study Arms (2)

Tab-G (tablet-based group CBT education)

EXPERIMENTAL

Tab-G participants will receive 4 weekly CBT(cognitive behavioral therapy)-based group learning sessions to encourage a simple walking activity through videoconferencing meetings in a group of 5 members. The educational materials emphasize shared goal setting and mutual reinforcement.

Behavioral: Tab-G

Usual care group

NO INTERVENTION

A usual care group will receive general arthritis management education. Participant are instructed to maintain usual activity during the study period.

Interventions

Tab-GBEHAVIORAL

Participants receive a tablet preloaded with Tab-G application and an accelerometer.

Also known as: tablet-based group CBT education
Tab-G (tablet-based group CBT education)

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of osteoarthritis or rheumatoid arthritis;
  • presence of greater than minimal fatigue scoring ≥13 (T-score\>55) on the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v1.0-Fatigue 6a; and
  • having Wi-Fi at home

You may not qualify if:

  • currently engaging in regular exercise;
  • non-ambulatory or presence of a condition that would limit the ability to walk (e.g., foot deformity, lower extremity joint surgery in past 6 months, stroke, severe chronic obstructive pulmonary disease, etc.); and
  • delirium, dementia, or any conditions indicating deteriorating cognitive status as determined by the Mini-Cog.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Massachusetts

Amherst, Massachusetts, 01003, United States

Location

MeSH Terms

Conditions

ArthritisFatigue

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jeungok Choi, PhD

    University of Massachusetts, Amherst

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study uses an experimental pre- and post-test repeated measures design. Those satisfying the inclusion and exclusion criteria are randomly assigned to the intervention (Tab-G, n=20) or comparison group (n=20).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

March 7, 2021

First Posted

March 11, 2021

Study Start

January 21, 2021

Primary Completion

April 30, 2023

Study Completion

April 30, 2023

Last Updated

May 9, 2023

Record last verified: 2023-05

Locations